Huntington's Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Huntington's Disease Treatment Market Report is Segmented by Type (Symptomatic Treatment and Disease-Modifying Therapies), End User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (USD) for the Above Segments.

Huntington's Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Huntington's Disease Treatment Industry Overview

The Huntington's disease treatment market is competitive with several large, small, and medium-sized players. Some of the companies dominating the market are Pfizer Inc., Alnylam Pharmaceuticals Inc., Ceregene Inc., Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd, Ionis Pharmaceuticals, Neurocrine Biosciences Inc., Prilenia Therapeutics, Azevan Pharmaceuticals, and Lundbeck.

Huntington's Disease Treatment Market Leaders

  1. Pfizer, Inc.

  2. Alnylam Pharmaceuticals Inc.

  3. Teva Pharmaceutical Industries Ltd.

  4. Neurocrine Biosciences, Inc.

  5. Ionis Pharmaceuticals

  6. *Disclaimer: Major Players sorted in no particular order
Huntington's Disease Treatment Market Concentration

Huntington's Disease Treatment Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?